1. Management of yolk sac tumor of the testis in children.
- Author
-
Lin JN, Wang KL, Hung IJ, and Yang CP
- Subjects
- Child, Preschool, Combined Modality Therapy, Endodermal Sinus Tumor drug therapy, Endodermal Sinus Tumor radiotherapy, Follow-Up Studies, Humans, Infant, Male, Taiwan, Testicular Neoplasms drug therapy, Testicular Neoplasms radiotherapy, Treatment Outcome, Endodermal Sinus Tumor surgery, Orchiectomy, Testicular Neoplasms surgery
- Abstract
Yolk sac tumor (YST) is the most common form of malignant testicular tumor in infancy and children. However, there is no general agreement on its treatment regimen due to its rare occurrence. From 1978 through 1990, 30 cases of YST of the testis were treated at Chang Gung Children's Hospital. Thirteen (43.3%) occurred in the right testis and 17 (56.7%) in the left. Age at operation ranged from six months to five years with a mean of 1.79 years. All patients received an orchidectomy as their initial treatment. Eighteen patients with stage I disease were treated by orchidectomy alone. Fourteen (77.8%) of them were free of disease, two patients who had recurrence with retroperitoneal metastasis were successfully treated with chemotherapy. The remaining two patients died of metastasis. Seven patients with stage II disease and five with stage III disease were treated with combination chemotherapy, irradiation or debulking operation following orchidectomy. Four stage II patients (57.1%) and one stage III patient (20%) showed no evidence of disease at the time of follow-up. It was concluded that for stage I disease, orchidectomy alone followed by strict monitoring of alpha- fetoprotein achieved an 89% disease-free survival rate. Retroperitoneal node dissection or routine chemotherapy added no benefit to survival. For stage II or III disease, chemotherapy or irradiation is needed to obtain a better outcome.
- Published
- 1994